<--- Back to Details
First PageDocument Content
Genetics / Immune system / Transplantation medicine / MHC Class II / Biology / Human leukocyte antigen / Transplant rejection / HLA-B / B27 / HLA-DR / History and naming of human leukocyte antigens
Date: 2015-12-21 15:13:10
Genetics
Immune system
Transplantation medicine
MHC Class II
Biology
Human leukocyte antigen
Transplant rejection
HLA-B
B27
HLA-DR
History and naming of human leukocyte antigens

Inland Northwest Blood Center

Add to Reading List

Source URL: inbcsaves.org

Download Document from Source Website

File Size: 25,71 KB

Share Document on Facebook

Similar Documents

Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis Jenny Link1., Malin Lundkvist Ryner1*., Katharina Fink1, Christina Herma

DocID: 1tQgK - View Document

Medicine / Gluten sensitivity / Clinical medicine / Health / Nexvax2 / Coeliac disease / HLA-DQ2 / Gluten challenge test / Human leukocyte antigen / HLA-DQ / Gluten-free diet / Autoimmunity

FOR IMMEDIATE RELEASE ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease - Data Presented at Digestive Disease Week 2016 CAMBRIDGE, Mass. – May 24, 2016 – ImmusanT, Inc., a clinical-stage company

DocID: 1r0rg - View Document

Genetics / Immune system / Transplantation medicine / MHC Class II / Biology / Human leukocyte antigen / Transplant rejection / HLA-B / B27 / HLA-DR / History and naming of human leukocyte antigens

Inland Northwest Blood Center

DocID: 1qGf9 - View Document

MHC Class II / Human leukocyte antigen / HLA-DP / HLA-DQB1 / HLA-DR

DE Information: Gebrauchsinformation Mastermixe/Magnesiumchlorid für HISTO SPOT® SSO Kits Testkits zur Typisierung von HLA Allelen auf molekulargenetischer Basis

DocID: 1pYNI - View Document

Genetics / Medicine / Clinical medicine / Immune system / HLA-B / HLA-A / StevensJohnson syndrome / Human leukocyte antigen / HLA-DRB1 / Carbamazepine / CBZ / Allopurinol

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor &alpha; antibody, in a phase I study of patients with mild asthma

DocID: 1pYBv - View Document